Net Income تغيير تاريخ
Acadia Pharmaceuticals USD 143.74M 110.98M 2024-12
Agios Pharmaceuticals USD -96523000 1.04B 2024-12
Alnylam Pharmaceuticals USD -83763000 27.81M 2024-12
Amgen USD 627M 2.2B 2024-12
Arrowhead Research USD -173085000 2.55M 2024-12
BioMarin Pharmaceutical USD 124.94M 18.86M 2024-12
Incyte USD 158.2M 43.01M 2025-03
Ionis Pharmaceuticals USD -146938000 42.59M 2025-03
Moderna USD -971000000 149M 2025-03
Neurocrine Biosciences USD 103.1M 26.7M 2024-12
Novartis USD 2.82B 371M 2024-12
PTC Therapeutics USD -65886000 40.77M 2024-12
Regeneron Pharmaceuticals USD 808.7M 109M 2025-03
Sanofi EUR 499M 2.32B 2024-12
Sarepta Therapeutics USD 159.05M 125.44M 2024-12
Takeda JPY 23.79B 68.26B 2024-12
Tectonic Therapeutic USD -12373000 5.34M 2024-12
Ultragenyx Pharmaceutical USD -133385000 131K 2024-12
Vertex Pharmaceuticals USD 913M 132.4M 2024-12
Xencor USD -53479000 8.34M 2024-12



Alnylam Pharmaceuticals صافي الدخل - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - May 2025.